Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis

Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis

This study is to determine symptomatic intracranial atherosclerotic stenosis (ICAS), a significant stroke cause with high recurrence risks, by examining the relationship between lipoprotein(a) and ischemic stroke recurrence. Analyzing data from the RICA trial (chronic remote ischemic conditioning in...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chuanjie Wu, Chengbei Hou, Wenbo Zhao, Chuanhui Li, Xuehong Chu, Longfei Wu, Yuan Wang, Chen Zhou, Guiyou Liu, Wanying Zhang, Ming Li, Zhengfei Ma, Yuchuan Ding, Ran Meng, Xunming Ji, Di Wu
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Neurotherapeutics
Subjects:	Lipoprotein(a) Remote ischemic conditioning Stroke Symptomatic intracranial atherosclerotic stenosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S1878747925000571
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between the triglyceride-glucose index and symptomatic intracranial atherosclerotic stenosis in nondiabetic patients: a retrospective study
by: Yang Yang, et al.
Published: (2025-08-01)

Risk factors of restenosis after paclitaxel-coated balloon treatment in symptomatic intracranial atherosclerotic disease
by: Yingkun Chen, et al.
Published: (2025-05-01)

Propensity score matched analysis of nationwide outcomes for intracranial bypass and stenting for treatment of intracranial atherosclerotic disease
by: Michael G. Brandel, et al.
Published: (2025-07-01)

Recanalization of atherosclerotic stenosis and occlusion of intracranial vertebrobasilar artery
by: Zhi-Long Zhou, et al.
Published: (2025-06-01)

Is it possible to regress atherosclerotic lesions with long-term treatment with lipoprotein apheresis?
by: Ulrich Julius, et al.
Published: (2024-10-01)

Evaluation of lipoprotein(a) — a novel cardiovascular risk factor in patients with atherosclerotic cardiovascular diseases receiving PCSK9-targeted therapy in Russian real-world practice
by: A. I. Sapina, et al.
Published: (2025-01-01)

Association between outdoor artificial light at night, circadian health, and LDL-C in intracranial artery atherosclerotic stenosis
by: Le Yang, et al.
Published: (2025-07-01)

Symptomatic posttreatment edema after stereotactic radiotherapy (SRS/FSRS) for intracranial meningiomas: patterns and predictive factors
by: Dorra Aissaoui, et al.
Published: (2025-09-01)

Evolocumab Added to Statin Is Associated With Intracranial Atherosclerotic Plaque Regression Compared With Statin Alone
by: Xinzhi Hu, et al.
Published: (2025-08-01)

NINJ1 and MMP9: potential biomarkers for intracranial atherosclerosis plaque vulnerability
by: Xiao-lian Wei, et al.
Published: (2025-04-01)

Low hemoglobin, albumin, lymphocyte, and platelet score increases symptomatic intracranial hemorrhage risk in thrombectomy patients
by: Shuaiyu Chen, et al.
Published: (2025-08-01)

Association of the triglyceride glucose-waist height ratio with asymptomatic intracranial arterial stenosis
by: Yumeng Yang, et al.
Published: (2025-04-01)

Assessment of the Utilization of Lipoprotein (a) and its Relationship with Cardiovascular Outcomes: A Retrospective Cohort Study from a Public Hospital in New York City
by: Maisha Maliha, et al.
Published: (2025-01-01)

EPIDEMIOLOGY OF SYMPTOMATIC EPILEPSIES IN SMOLENSK REGION
by: N. N. Maslova, et al.
Published: (2016-05-01)

Clinical Manifestations of Symptomatic Intracranial Hemorrhage in Term Neonates: 18 Years of Experience in a Medical Center
by: Mei-Chen Ou-Yang, et al.
Published: (2010-08-01)

Colchicine for preventing stroke in patients with and without intracranial atherosclerotic stenosis: a prespecified analysis of a randomized clinical trialResearch in context
by: Jiejie Li, et al.
Published: (2025-06-01)

METHODS FOR CELLULAR AND MOLECULAR COMPOUND OF ATHEROSCLEROTIC PLAQUES ASSESSMENT: LITERARY REVIEW
by: Yu. V. Saranchina, et al.
Published: (2017-10-01)

Efficacy and safety of balloon dilation versus stent implantation in young ischemic stroke patients with symptomatic intracranial artery stenosis
by: ZHANG He, et al.
Published: (2025-05-01)

Results of Surgical Treatment of Patients with Symptomatic Abdominal Aortic Aneurysms
by: I. P. Mikhailov, et al.
Published: (2024-04-01)

Characteristics of symptomatic epilepsy and other neurological disorders in children with lissencephaly
by: V. I. Guzeva, et al.
Published: (2018-03-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Neutrophil extracellular traps and echogenicity of carotid atherosclerotic plaques
by: I. I. Dolgushin, et al.
Published: (2020-12-01)

OSTEONECTIN AND SELECTED BIOMARKERS IN ATHEROSCLEROTIC OCCLUSION AND CALCINOSIS OF CORONARY ARTERIES
by: Yu. I. Ragino, et al.
Published: (2010-08-01)

Mortality-Related Factors and 1-Year Survival in Patients After Intracranial Stenting for Intracranial Arterial Critical Stenosis and Occlusion
by: Yusuf Inanc, et al.
Published: (2025-02-01)

Identifying the risk factors for intracranial herniation in patients with cerebral venous thrombosis
by: Yasemin Dinç, et al.
Published: (2023-05-01)

Inhibitors in the Management of Patients with Atherosclerotic Cardiovascular Diseases: Guidelines and Reimbursement Issues
by: M. V. Zhuravleva, et al.
Published: (2020-09-01)

Role of thromboelastography in predicting stroke risk after endovascular treatment for symptomatic intracranial atherosclerotic stenosis
by: Bo Zhou, et al.
Published: (2025-07-01)

Neovascularization in Atherosclerotic Plaques: Clinical Implications, Detection, and Prevention Strategies
by: Long Zhang, et al.
Published: (2025-07-01)

Atherosclerotic plaque in carotid arteries as a risk marker for cardiovascular events risk in middle aged population
by: A. I. Ershova, et al.
Published: (2018-08-01)

Acute Traumatic Intracranial Hematoma Index and its Significance for Objectifying Indications for Their Surgical Treatment
by: A. V. Semyonov, et al.
Published: (2020-01-01)

Symptomatic Vocabulary in Magn Function
by: E. R. Ioanesyan
Published: (2019-02-01)

Penetrating atherosclerotic ulcer of the ascending aorta
by: S. Yu. Boldyrev, et al.
Published: (2020-06-01)

Analysis of influencing factors for primary membranous nephropathy complicated with atherosclerotic cardiovascular disease and establishment of a nomogram prediction model
by: Mirixiatijiang· Maimaiti, et al.
Published: (2025-03-01)

Evaluation of the effect of statin treatment on intracranial atherosclerotic plaques using magnetic resonance vessel wall imaging: a case series
by: Ke Yang, et al.
Published: (2025-03-01)

Breast arterial calcification and carotid arteries atherosclerotic load in women
by: I. V. Kim, et al.
Published: (2024-07-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

Advantages of osteoarthritis combined treatment with symptomatic slow-acting drugs
by: E. V. Zonova
Published: (2021-04-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

CURRENT PHARMACOTHERAPY FOR KNEE OSTEOARTHRITIS: SPECIFIC FEATURES OF SYMPTOMATIC AND DISEASE MODIFYING EFFECTS. COMMUNICATION 1. SPECIFIC FEATURES OF THE SYMPTOMATIC EFFECTS OF CURRENT DRUGS TO TREAT KNEE OSTHEOARTHRITIS
by: E. S. Tsvetkova, et al.
Published: (2015-03-01)

Treatment strategies for unruptured intracranial aneurysms in the Chinese population: China Treatment Trial for Unruptured Intracranial Aneurysm (ChTUIA)
by: Kaige Zheng, et al.
Published: (2025-04-01)